PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
3.770
-0.210 (-5.28%)
At close: Jul 25, 2025, 4:00 PM
3.671
-0.099 (-2.64%)
After-hours: Jul 25, 2025, 7:32 PM EDT

Company Description

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.

The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.

It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.

The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc.
PetMed Express logo
CountryUnited States
Founded1996
IndustryPharmaceutical Retailers
SectorHealthcare
Employees287
CEOSandra Campos

Contact Details

Address:
420 South Congress Avenue
Delray Beach, Florida 33445
United States
Phone561 526 4444
Website1800petmeds.com

Stock Details

Ticker SymbolPETS
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyUSD
CIK Code0001040130
CUSIP Number716382106
ISIN NumberUS7163821066
Employer ID65-0680967
SIC Code5912

Key Executives

NamePosition
Sandra Y. CamposPresident, Chief Executive Officer and Director
Robyn DEliaChief Financial Officer
Caroline ConeglianoChief Operating Officer
Doug KrulikChief Accounting Officer
Carla DoddsChief Marketing Officer
Jacqueline SmithVice President of People
Umesh SripadChief Digital and Technology Officer
Wendy ZalaiCorporate Controller and Corporate Secretary

Latest SEC Filings

DateTypeTitle
Jul 3, 20258-KCurrent Report
Jul 1, 20258-KCurrent Report
Jun 16, 20258-KCurrent Report
Jun 16, 2025NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
May 20, 2025SCHEDULE 13DFiling
Apr 9, 20258-KCurrent Report
Apr 3, 2025SCHEDULE 13G/AFiling
Mar 10, 2025SCHEDULE 13GFiling
Feb 14, 2025SCHEDULE 13G/AFiling
Feb 10, 202510-QQuarterly Report